Ewing sarcoma
2018 · Nature Reviews Disease Primers · 805 citations
https://doi.org/10.1038/s41572-018-0003-x
D
Didier Surdez
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
235
Papers
8.0K
Citations
35
h-index
60
i10-index
Didier Surdez is an academic researcher from University Hospital of Zurich. The author has contributed to research in topics: Sarcoma Diagnosis and Treatment & Neuroblastoma Research and Treatments & Cancer, Hypoxia, and Metabolism. The author has an h-index of 35, co-authored 200 publications.
ORCID: 0000-0002-7118-7859Papers by this author
worksHeterogeneity of neuroblastoma cell identity defined by transcriptional circuitries
2017 · Nature Genetics · 502 citations
https://doi.org/10.1038/ng.3921
Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors
2020 · Nature Medicine · 296 citations
https://doi.org/10.1038/s41591-020-0821-8
Class I <scp>HDAC</scp> inhibitors enhance <scp>YB</scp> ‐1 acetylation and oxidative stress to block sarcoma metastasis
2019 · EMBO Reports · 110 citations
https://doi.org/10.15252/embr.201948375
Systematic multi-omics cell line profiling uncovers principles of Ewing sarcoma fusion oncogene-mediated gene regulation
2022 · Cell Reports · 75 citations
https://doi.org/10.1016/j.celrep.2022.111761
SMARCB1 regulates a TFCP2L1-MYC transcriptional switch promoting renal medullary carcinoma transformation and ferroptosis resistance
2023 · Nature Communications · 32 citations
https://doi.org/10.1038/s41467-023-38472-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat